A Study of Lumasiran in Infants and Young Children With Primary Hyperoxaluria Type 1

Clinical trial NCT03905694 · COMPLETED

Trial details

NCT number: NCT03905694
Sponsor: Alnylam Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Primary Hyperoxaluria Primary Hyperoxaluria Type 1 (PH1)

Start date: 2019-04-22
Primary completion: 2020-06-29
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.